Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Filings indexed 1,213 across all filing types
Latest filing 2023-07-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from the board of directors regarding an update on product development, specifically the approval for drug production and registration. It is not a financial report, earnings release, or regulatory filing related to financial performance. The document is short (1613 characters) and serves to inform shareholders and investors about business developments rather than financial results or governance changes. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is an announcement of business development, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2023-07-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report on movements in securities, specifically focusing on authorized and issued share capital, share options, and confirmations related to securities issued by SSY Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content is regulatory in nature, providing updates on share capital and share issuance movements rather than financial performance or management commentary. It does not contain financial statements or earnings data, nor is it a meeting presentation or voting result. It is a regulatory compliance filing related to share capital movements and confirmations. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-06-30 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from the board of directors regarding an update on product development, specifically the approval for drug production and registration. It is not a financial report, earnings release, or regulatory filing related to financial performance. The document is short (1809 characters) and serves to inform shareholders and investors about business developments rather than financial results or governance changes. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is an announcement of business progress, which aligns best with a general Regulatory Filing (RNS) as it does not fit other specific categories.
2023-06-29 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement from the board of directors about the approval for drug production and registration. It is a brief update on product development and does not contain financial data, detailed reports, or regulatory certifications. The document is short (1566 characters) and serves to inform shareholders and investors about business progress rather than financial results or governance changes. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a regulatory filing or certification either. The best fitting category is a general Regulatory Filing (RNS) as it is a miscellaneous announcement that does not fit other specific categories.
2023-06-13 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by the board of directors regarding the approval of a new drug product by a regulatory authority. It is an update on product development and does not contain financial data, financial results, or detailed report content. The document is short (1760 characters) and serves to inform shareholders and investors about business developments rather than presenting a formal report or financial statements. It is not an Annual Report, Interim Report, Earnings Release, or any other detailed financial or regulatory filing. It is also not a report publication announcement since it does not mention any report being attached or published. The content fits best under a general regulatory announcement category that informs about business updates without fitting into other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-06-02 English
Monthly Return of Equity Issuer on Movements in Securities
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report on movements in securities for SSY Group Limited, including authorized share capital, issued shares, share options, repurchases, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with listing rules. The content focuses on share capital changes and share repurchases during the month ended 31 May 2023. It is not a financial report like an annual or interim report, nor is it a simple announcement or certification. The document fits the category of Share Issue/Capital Change (SHA) because it reports on share capital movements, share options, and share repurchases, which are capital changes.
2023-05-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.